Document is current
Any future updates will be listed below
-
Authors
Di Maio, Silvia
Grüneis, Rebecca
Streiter, Gertraud
Lamina, Claudia
Maglione, Manuel
Schoenherr, Sebastian
Öfner, Dietmar
Thorand, Barbara
Peters, Annette
Eckardt, Kai-Uwe
Köttgen, Anna
Kronenberg, Florian
Coassin, Stefan https://orcid.org/0000-0001-5677-8979
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P31458, P266600-B13, GOLD project)
- License Information
-
More Information
Article History
Received: 27 March 2020
Accepted: 5 August 2020
First Online: 21 August 2020
Ethics approval and consent to participate
: All studies have been approved by the respective institutional review boards. These are the Bayerische Landesärztekammer for the KORA studies (EC No. 03097, EC No. 06068.) and the ethics committees of all participating institutions for GCKD (Friedrich-Alexander-University Erlangen-Nürnberg, Medical Faculty of the Rheinisch-Westfälische Technische Hochschule Aachen, Charité—University Medicine Berlin, Medical Center—University of Freiburg, Medizinische Hochschule Hannover, Medical Faculty of the University of Heidelberg, Friedrich-Schiller-University Jena, Medical Faculty of the Ludwig-Maximilians-University Munich, Medical Faculty of the University of Würzburg). CAVASIC has been approved by the review boards of the Medical University of Innsbruck, Austria (AN20102167), and the Third Medical Department of Metabolic Diseases and Nephrology, Hietzing Hospital, Vienna, Austria (EK-03-052-0503). Liver tissue specimen collection for Lp(a) research was approved by the IRB of the Medical University of Innsbruck (IRB Medical University of Innsbruck, AN2015-0056). Informed consent was obtained from all participants, and all studies were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
